Can anesthesia hide the trip? new study tests psilocybin for depression

NCT ID NCT07479550

First seen Mar 18, 2026 · Last updated Jun 16, 2026 · Updated 19 times

Summary

This study tests a new way to study psilocybin for major depression by giving it while people are under general anesthesia. The goal is to hide the drug's noticeable effects so neither participants nor researchers know who got the real drug, making the results more reliable. Ten adults with depression will receive either psilocybin or placebo across four sessions. The study checks if this approach is safe and if it might help reduce depression symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Stanford University

    Stanford, California, 94304, United States

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.